XML 60 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Share-based compensation expense related to share options, RSUs and grants under our ESPP was as follows (in thousands): 
 
Three Months Ended
March 31,
 
2020
 
2019
Selling, general and administrative
$
20,596

 
$
20,370

Research and development
6,385

 
5,523

Cost of product sales
1,673

 
1,659

Total share-based compensation expense, pre-tax
28,654

 
27,552

Income tax benefit from share-based compensation expense
(3,746
)
 
(3,667
)
Total share-based compensation expense, net of tax
$
24,908

 
$
23,885


Share Options
The table below shows the number of shares underlying options granted to purchase our ordinary shares, the weighted-average assumptions used in the Black-Scholes option pricing model and the resulting weighted-average grant date fair value of share options granted: 
 
Three Months Ended
March 31,
 
2020
 
2019
Shares underlying options granted (in thousands)
565

 
1,297

Grant date fair value
$
33.65

 
$
42.84

Black-Scholes option pricing model assumption information:
 
 
 
Volatility
32
%
 
32
%
Expected term (years)
4.6

 
4.5

Range of risk-free rates
0.8-1.6%

 
2.4-2.5%

Expected dividend yield
%
 
%

Restricted Stock Units
The table below shows the number of RSUs granted covering an equal number of our ordinary shares and the weighted-average grant date fair value of RSUs granted:
 
Three Months Ended
March 31,
 
2020
 
2019
RSUs granted (in thousands)
959

 
519

Grant date fair value
$
114.19

 
$
139.38


The fair value of RSUs is determined on the date of grant based on the market price of our ordinary shares on that date. The fair value of RSUs is expensed ratably over the vesting period, generally over four years.
As of March 31, 2020, compensation cost not yet recognized related to unvested share options and RSUs was $82.5 million and $166.0 million, respectively, which is expected to be recognized over a weighted-average period of 2.7 years and 3.2 years, respectively.